Latest news from Cochrane
- Cochrane's statement to the 74th World Health Assembly (1 June 2021)
- Cochrane shows support for WHO-ICMRA statement on transparency and data integrity (7 May 2021)
- Cochrane signs letter asking medicines regulators in Europe to address unpublished clinical trials (10 May 2021)
- New independent study finds Cochrane’s transparency over reporting financial conflicts of interest is leading the way 20 May 2020
- Cochrane Centres call for transparency of COVID-19 clinical studies 20 May 2020
- Cochrane's statement to the 73rd World Health Assembly 18 May 2020
- Cochrane’s statement in support of EMA’s clinical study report transparency policy 13 January 2020
- BMJ blog: Karla Soares-Weiser: Cochrane announces a new, more rigorous “conflict of interest” policy 3 December 2019
- Cochrane supports AllTrials report on UK clinical trial transparency used as a basis for parliament evidence session 8 November 2019
- Cochrane advocates for clinical trial transparency at EU Parliament event 25 October 2019
- 2019 Cochrane-REWARD Prize winners announced 18 October 2019
- Cochrane CSR Working Group’s open letter in response to the FDA’s public comment request on the Clinical Data Summary Report Pilot 22 August 2019
- Cochrane supports European regulators as they urge clinical trial sponsors to share their results 10 July 2019
Resources and activities from Cochrane Groups
- Watch the video: Cochrane Sweden host webinar on clinical trial transparency
- US FDA begins enforcement of clinical trial transparency regulation
- Cochrane Belgium partners on clinical trial transparency report
- Cochrane Austria launches joint trial transparency report
- Cochrane Sweden highlights under-reporting of Swedish clinical trials
- Cochrane Germany explains why a lack of trial transparency harms health